Summary

The team led by Aaban discussed the funding policy review, focusing on eligibility, transition, and co-financing policies, and proposed shifts to address challenges and improve the program's success. They also discussed the cost-effectiveness of vaccines, the challenges faced by countries in the preparatory transition phase, and a new strategy to support countries in their transition to new vaccines. Lastly, they addressed the expanding mandate of Gabby, the transition of country teams in Gavi, and the development of a new strategic approach for the 5.1 strategic period.